Megalin-based delivery of therapeutic compounds to the brain and other tissues
US8609103B2 · kind B2 · utility
3Cited by
26References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 8, 2010 |
| Grant date | Dec 17, 2013 |
| Priority date | — |
| Expiry date | Feb 5, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/23
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to a methods and compositions for receptor mediated drug delivery, particularly across the blood-brain barrier.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.